Voyagers Capital
Qiming Leads $12M Round for Heart Pump Maker Enginprime
Enginprime Medical, a Shanghai and Hangzhou-based developer of percutaneous ventricular assist device (pVAD) technology, announced on August 17 that it has closed a $12 million Series A financing round exclusively led by Qiming Venture Partners, a large, established venture capital firm. Proceeds will fund a registration clinical trial of Enginprime’s lead device, OpusOne, in China,…
